Why the study?
Is an intermediate anticoagulation regimen (INR 2.0 to 3.0) safe regarding the risk of intracranial hemorrhage in patients with cerebral ischemia of arterial origin?
Is an intermediate anticoagulation regimen (INR 2.0 to 3.0) safe regarding the risk of intracranial hemorrhage in patients with cerebral ischemia of arterial origin?
An intermediate anticoagulation regimen (INR 2.0 to 3.0) appears reasonably safe regarding intracranial hemorrhage risk in patients with cerebral ischemia of arterial origin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Michael G. Hennerici (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: